HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Daniel E Johnson Selected Research
Daniel E Johnson Research Topics
Disease
53
Neoplasms (Cancer)
10/2023 - 07/2002
46
Squamous Cell Carcinoma of Head and Neck
10/2023 - 04/2003
23
Head and Neck Neoplasms (Head and Neck Cancer)
10/2023 - 04/2003
7
Carcinogenesis
01/2023 - 08/2012
3
Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2020 - 09/2003
3
Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
11/2018 - 12/2007
3
Leukemia
07/2015 - 01/2005
2
Mouth Neoplasms (Oral Cancer)
08/2016 - 07/2016
2
Multiple Myeloma
02/2015 - 12/2012
2
Prostatic Neoplasms (Prostate Cancer)
06/2006 - 07/2004
1
Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2023
1
Bites and Stings (Sting)
10/2021
1
Stroke (Strokes)
02/2021
1
Laryngeal Neoplasms (Laryngeal Cancer)
11/2020
1
Myeloproliferative Disorders (Myeloproliferative Disorder)
01/2020
1
Colorectal Neoplasms (Colorectal Cancer)
01/2020
1
Rheumatoid Arthritis
01/2020
1
Ataxia Telangiectasia (Louis Bar Syndrome)
01/2019
1
Pharyngeal Neoplasms
06/2017
1
Papillomavirus Infections
06/2017
Drug/Important Bio-Agent (IBA)
17
Proteins (Proteins, Gene)
FDA Link
11/2021 - 11/2004
11
Biomarkers (Surrogate Marker)
IBA
10/2023 - 08/2016
10
Cetuximab (Erbitux)
FDA Link
11/2021 - 11/2009
7
ErbB Receptors (EGF Receptor)
IBA
01/2022 - 09/2003
7
Proteasome Inhibitors
IBA
02/2015 - 06/2008
6
Cisplatin (Platino)
FDA Link
Generic
01/2023 - 06/2008
6
Bortezomib (Velcade)
FDA Link
02/2015 - 06/2008
5
Oligonucleotides
IBA
01/2020 - 04/2003
5
STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)
IBA
10/2019 - 04/2003
4
RNA (Ribonucleic Acid)
IBA
01/2023 - 03/2013
4
Transcription Factors (Transcription Factor)
IBA
01/2023 - 04/2003
4
Tyrosine Kinase Inhibitors
IBA
01/2022 - 01/2017
4
Caspase 8 (Caspase-8)
IBA
01/2021 - 10/2014
4
carfilzomib
IBA
02/2015 - 10/2012
3
Non-Steroidal Anti-Inflammatory Agents (NSAIDs)
IBA
01/2022 - 01/2019
3
Immune Checkpoint Inhibitors
IBA
10/2021 - 12/2018
3
Monoclonal Antibodies
IBA
11/2020 - 01/2017
3
sulforaphane
IBA
12/2019 - 06/2006
3
Tyrosine (L-Tyrosine)
FDA Link
01/2019 - 01/2016
3
Tretinoin (Retinoic Acid)
FDA Link
Generic
11/2018 - 12/2007
3
Oncogene Proteins (Oncogene Protein)
IBA
01/2018 - 07/2002
3
ONX 0912
IBA
09/2014 - 10/2012
2
Alpelisib
IBA
10/2023 - 11/2021
2
Enzymes
IBA
01/2023 - 01/2021
2
Dinoprostone (PGE2)
FDA Link
01/2023 - 01/2020
2
Messenger RNA (mRNA)
IBA
10/2021 - 01/2016
2
Cytokines
IBA
01/2021 - 01/2020
2
Nucleotides
IBA
01/2020 - 10/2019
2
Interleukin-6 (Interleukin 6)
IBA
01/2020 - 01/2018
2
Phosphotransferases (Kinase)
IBA
01/2020 - 01/2019
2
Death Domain Receptors
IBA
01/2018 - 10/2014
2
Erlotinib Hydrochloride (CP 358,774)
FDA Link
01/2017 - 11/2009
2
Carcinogens
IBA
08/2016 - 07/2016
2
Proteasome Endopeptidase Complex (Proteasome)
IBA
02/2015 - 03/2013
2
Annexin A5
IBA
02/2014 - 10/2007
2
pregna-4,17-diene-3,16-dione (guggulsterone)
IBA
11/2009 - 08/2009
2
Etoposide (VP 16)
FDA Link
Generic
05/2009 - 05/2005
2
Peptides (Polypeptides)
IBA
05/2009 - 10/2007
2
Cytochromes c (Cytochrome c)
IBA
10/2007 - 06/2006
1
tipifarnib (R115777)
IBA
10/2023
1
ruxolitinib
IBA
11/2022
1
Immune Checkpoint Proteins
IBA
11/2021
1
Fibronectins (Fibronectin)
IBA
10/2021
1
Caveolin 1
IBA
10/2021
1
Protein Isoforms (Isoforms)
IBA
10/2021
1
Protein-Tyrosine Kinases (Tyrosine Kinase)
IBA
10/2021
1
Mutant Proteins (Protein, Mutant)
IBA
10/2021
1
Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)
IBA
10/2021
1
Cytotoxins (Cytolysins)
IBA
10/2021
1
Guanine Nucleotide Exchange Factors (Guanine Nucleotide Exchange Factor)
IBA
10/2021
1
Protein Kinases (Protein Kinase)
IBA
10/2021
1
Doxycycline (Periostat)
FDA Link
Generic
01/2021
1
Deubiquitinating Enzymes
IBA
01/2021
1
Lysine (L-Lysine)
FDA Link
01/2021
1
pembrolizumab
IBA
11/2020
1
Nivolumab
IBA
11/2020
1
Janus Kinases
IBA
01/2020
1
Glycogen Synthase Kinase 3
IBA
01/2020
1
Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)
IBA
01/2020
1
Janus Kinase Inhibitors
IBA
01/2020
1
Therapeutic Uses
IBA
01/2020
1
Ligands
IBA
12/2019
1
Agent M
IBA
01/2019
1
ceralasertib
IBA
01/2019
1
src-Family Kinases
IBA
11/2018
1
Dasatinib (BMS 354825)
FDA Link
11/2018
1
Chimeric Antigen Receptors
IBA
01/2018
1
Cell Surface Receptors
IBA
01/2018
1
Interleukin-6 Receptors (Interleukin 6 Receptor)
IBA
01/2018
1
Antineoplastic Agents (Antineoplastics)
IBA
01/2018
1
Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)
IBA
06/2017
Therapy/Procedure
26
Therapeutics
10/2023 - 01/2005
9
Drug Therapy (Chemotherapy)
11/2020 - 07/2002
4
Chemoprevention
12/2019 - 06/2015
3
Precision Medicine
10/2023 - 12/2018
3
Immunotherapy
01/2022 - 01/2018
2
Radiotherapy
10/2021 - 07/2002
1
Toothbrushing
02/2021
1
Chemoradiotherapy
11/2020
1
Microbubbles
01/2020